<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00828841</url>
  </required_header>
  <id_info>
    <org_study_id>AC01L08</org_study_id>
    <nct_id>NCT00828841</nct_id>
  </id_info>
  <brief_title>Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC</brief_title>
  <official_title>A Multi-Center Randomized Phase 2b Study of Cetuximab (Erbitux) in Combination With Platinum-Based Chemotherapy as First Line Treatment of Patients With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Accelerated Community Oncology Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Accelerated Community Oncology Research Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is testing the investigational drug, cetuximab, in combination with different
      chemotherapy drugs for lung cancer. The aim of the study is to determine which of the drug
      combinations looks most promising and should be tested further. The study will also look at
      what side effects may occur.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival by Treatment Arm</measure>
    <time_frame>Survival was measured from the date of randomization to date of death due to any cause, assessed up to 36 months. Subjects who were alive at the date of last contact were censored at the date of last contact.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1-year Survival by Treatment Arm</measure>
    <time_frame>Survival was measured from the date of randomization to date of death due to any cause, assessed up to 36 months. Subjects who were alive at the date of last contact were censored at the date of last contact.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival by Histology</measure>
    <time_frame>Survival was measured from the date of randomization to date of death due to any cause, assessed up to 36 months. Subjects who were alive at the date of last contact were censored at the date of last contact.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">601</enrollment>
  <condition>Non-Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Paclitaxel, Carboplatin, Cetuximab (Arm A)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with squamous or non-squamous histologies will receive carboplatin and paclitaxel for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Platinum, Gemcitabine, Cetuximab (Arm B)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with squamous or non-squamous histologies will receive gemcitabine with either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Platinum, Pemetrexed, Cetuximab (Arm C)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with squamous histology will receive pemetrexed and either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion. Patients with non-squamous histology are not eligible for this arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cetuximab</intervention_name>
    <description>Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
    <arm_group_label>Paclitaxel, Carboplatin, Cetuximab (Arm A)</arm_group_label>
    <arm_group_label>Platinum, Gemcitabine, Cetuximab (Arm B)</arm_group_label>
    <arm_group_label>Platinum, Pemetrexed, Cetuximab (Arm C)</arm_group_label>
    <other_name>Erbitux</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paclitaxel</intervention_name>
    <description>Paclitaxel 200 mg/m2 Day 1 every 21 days</description>
    <arm_group_label>Paclitaxel, Carboplatin, Cetuximab (Arm A)</arm_group_label>
    <other_name>Taxol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Carboplatin</intervention_name>
    <description>Carboplatin AUC 6 Day 1 every 21 days</description>
    <arm_group_label>Paclitaxel, Carboplatin, Cetuximab (Arm A)</arm_group_label>
    <arm_group_label>Platinum, Gemcitabine, Cetuximab (Arm B)</arm_group_label>
    <arm_group_label>Platinum, Pemetrexed, Cetuximab (Arm C)</arm_group_label>
    <other_name>Paraplatin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gemcitabine</intervention_name>
    <description>Gemcitabine 1,000 mg/m2 Days 1 and 8 every 21 days</description>
    <arm_group_label>Platinum, Gemcitabine, Cetuximab (Arm B)</arm_group_label>
    <other_name>Gemzar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cisplatin</intervention_name>
    <description>Cisplatin 75 mg/m2 Day I every 21 days</description>
    <arm_group_label>Platinum, Gemcitabine, Cetuximab (Arm B)</arm_group_label>
    <arm_group_label>Platinum, Pemetrexed, Cetuximab (Arm C)</arm_group_label>
    <other_name>Platinol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent before study-related activities

          -  Histologically or cytologically confirmed Stage IIIb with cytologically documented
             malignant pleural or pericardial effusion, Stage IV, or recurrent non-smal cell lung
             cancer (NSCLC) after resection or radiation for earlier stage disease

          -  Measurable or evaluable disease (per modified Response Evaluation Criteria in Solid
             Tumors [RECIST] guidelines)

          -  Male or female ≥ 18 years of age

          -  Eastern Cooperative Oncology Group (ECOG) performance status of 0-1

          -  White blood count ≥ 3 x 10(9)/L with neutrophils ≥ 1.5 x 10(9)/L, platelet count ≥ 100
             x 10(9)/L, and hemoglobin ≥ 9.5 g/dL

          -  Total bilirubin ≤ 1.5 x upper limit of normal (ULN)

          -  Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 x ULN or ≤ 5
             x ULN in patients with liver mets

          -  Serum creatinine ≤ 1.25 x ULN

          -  Recovery from prior surgery or radiation to Grade 1 or better toxicity

          -  Women of childbearing potential (WOCBP) and fertile men with partners of childbearing
             potential must be using an adequate method of contraception to avoid pregnancy
             throughout the study and for up to 4 wks after the study in such a manner that the
             risk of pregnancy is minimized

          -  WOCBP must have a negative serum or urine pregnancy test within 72 hrs prior to the
             start of study medication or in accordance with local regulations, whichever is of
             shorter duration

        Exclusion Criteria:

          -  WOCBP who are unwilling or unable to use an acceptable method of birth control to
             avoid pregnancy for the entire study period and for up to 4 weeks after the study

          -  Women who are pregnant or breastfeeding

          -  Women with a positive pregnancy test during screening or prior to study drug
             administration

          -  Sexually active fertile men not using effective birth control if their partners are
             women of child-bearing potential

          -  Prior chemo for advanced NSCLC; neoadjuvant or post-operative adjuvant chemo is
             allowed if completed at least 12 months before study entry

          -  Previous exposure to epidermal growth factor receptor (EGFR)-targeted therapy. Prior
             treatment with monoclonal antibodies targeting receptors other than the EGFR, such as
             bevacizumab, is allowed if completed &gt; 30 days prior to randomization

          -  Treatment with any investigational agent(s) within 4 weeks prior to study entry

          -  Concurrent anti-cancer therapy (chemotherapy, hormonal therapy, biologic or targeted
             therapy) other than protocol therapy

          -  Carcinoid, atypical carcinoid or small cell lung cancer

          -  Symptomatic or uncontrolled mets in the central nervous system

          -  Prior invasive malignancy requiring ongoing therapy within the past year

          -  Active infection (infection requiring intravenous [IV] antibiotics), including active
             tuberculosis, known and declared HIV

          -  Myocardial infarction within 6 months prior to study entry, uncontrolled congestive
             heart failure; or any current Grade 3 or 4 cardiovascular disorder despite treatment

          -  Known allergic/hypersensitivity reaction to any of the components of study treatments

          -  Peripheral neuropathy ≥ Grade 2, as assessed by Common Terminology Criteria for
             Adverse Events, version 3.0

          -  History of significant neurologic or psychiatric disorders including but not limited
             to dementia, seizures, and bipolar disorder

          -  Medical or psychological condition that would not permit the patient to complete the
             study or sign informed consent

          -  Known drug abuse

        Patients of all races and ethnic groups are eligible for this trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lee Schwartzberg, MD, FACP</last_name>
    <role>Study Chair</role>
    <affiliation>Accelerated Community Oncology Research Network</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Anniston</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Azusa</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Burbank</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Campbell</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greenbrae</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hawthorne</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mission Hills</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orange</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oxnard</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Helena</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norwich</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Torrington</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Trumbull</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lake Worth</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orange City</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Titusville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Weston</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lawrenceville</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Valdosta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elmhurst</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Harvey</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Joliet</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Quincy</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Medicine of Vincennes</name>
      <address>
        <city>Vincennes</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arnes</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bettendorf</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mason City</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Waterloo</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hazard</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Worchester</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jefferson City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Joseph</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Billings</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Grand Island</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Portsmouth</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bellville</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cherry Hill</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elizabeth</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>East Setauket</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fresh Meadows</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fayetteville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gastonia</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Goldsboro</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Middletown</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sandusky</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Reading</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sumter</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Beaumont</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bennington</city>
        <state>Vermont</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kirkland</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wauwatosa</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2009</study_first_submitted>
  <study_first_submitted_qc>January 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2009</study_first_posted>
  <results_first_submitted>August 7, 2013</results_first_submitted>
  <results_first_submitted_qc>August 7, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 11, 2013</results_first_posted>
  <last_update_submitted>October 11, 2013</last_update_submitted>
  <last_update_submitted_qc>October 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Gemcitabine</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
    <mesh_term>Cisplatin</mesh_term>
    <mesh_term>Carboplatin</mesh_term>
    <mesh_term>Cetuximab</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was open to enrollment at 118 oncology clinics from November 2008 to May 2011.</recruitment_details>
      <pre_assignment_details>Consent was obtained from all subjects. Subjects were stratified by histology (non-squamous vs. squamous), followed by disease stage (IIIb vs. IV). Subjects in the non-squamous stratum were randomized to 1 of 3 treatment arms (Arm A, B, or C); subjects in the squamous stratum were randomized to only 1 of 2 of these treatment arms (Arm A or B).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Paclitaxel, Carboplatin, Cetuximab (Arm A)</title>
          <description>Patients with squamous or non-squamous histologies will receive carboplatin and paclitaxel for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion.
Paclitaxel : Paclitaxel 200 mg/m2 Day 1 every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
        </group>
        <group group_id="P2">
          <title>Platinum, Gemcitabine, Cetuximab (Arm B)</title>
          <description>Patients with squamous or non-squamous histologies will receive gemcitabine with either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion.
Gemcitabine : Gemcitabine 1,000 mg/m2 Days 1 and 8 every 21 days
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
        </group>
        <group group_id="P3">
          <title>Platinum, Pemetrexed, Cetuximab (Arm C)</title>
          <description>Patients with squamous histology will receive pemetrexed and either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion. Patients with non-squamous histology are not eligible for this arm.
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="235"/>
                <participants group_id="P2" count="236"/>
                <participants group_id="P3" count="130"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="231"/>
                <participants group_id="P2" count="232"/>
                <participants group_id="P3" count="126"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Paclitaxel, Carboplatin, Cetuximab (Arm A)</title>
          <description>Patients with squamous or non-squamous histologies will receive carboplatin and paclitaxel for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion.
Paclitaxel : Paclitaxel 200 mg/m2 Day 1 every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
        </group>
        <group group_id="B2">
          <title>Platinum, Gemcitabine, Cetuximab (Arm B)</title>
          <description>Patients with squamous or non-squamous histologies will receive gemcitabine with either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion.
Gemcitabine : Gemcitabine 1,000 mg/m2 Days 1 and 8 every 21 days
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
        </group>
        <group group_id="B3">
          <title>Platinum, Pemetrexed, Cetuximab (Arm C)</title>
          <description>Patients with squamous histology will receive pemetrexed and either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion. Patients with non-squamous histology are not eligible for this arm.
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="235"/>
            <count group_id="B2" value="236"/>
            <count group_id="B3" value="130"/>
            <count group_id="B4" value="601"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.3" spread="8.9"/>
                    <measurement group_id="B2" value="64.9" spread="9.5"/>
                    <measurement group_id="B3" value="65.6" spread="9.4"/>
                    <measurement group_id="B4" value="65.2" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="90"/>
                    <measurement group_id="B3" value="64"/>
                    <measurement group_id="B4" value="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="138"/>
                    <measurement group_id="B2" value="146"/>
                    <measurement group_id="B3" value="66"/>
                    <measurement group_id="B4" value="350"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="235"/>
                    <measurement group_id="B2" value="236"/>
                    <measurement group_id="B3" value="130"/>
                    <measurement group_id="B4" value="601"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Overall Survival by Treatment Arm</title>
        <time_frame>Survival was measured from the date of randomization to date of death due to any cause, assessed up to 36 months. Subjects who were alive at the date of last contact were censored at the date of last contact.</time_frame>
        <population>Two subjects in Arm A were censored due to negative event intervals.</population>
        <group_list>
          <group group_id="O1">
            <title>Paclitaxel, Carboplatin, Cetuximab (Arm A)</title>
            <description>Patients with squamous or non-squamous histologies will receive carboplatin and paclitaxel for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion.
Paclitaxel : Paclitaxel 200 mg/m2 Day 1 every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
          </group>
          <group group_id="O2">
            <title>Platinum, Gemcitabine, Cetuximab (Arm B)</title>
            <description>Patients with squamous or non-squamous histologies will receive gemcitabine with either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion.
Gemcitabine : Gemcitabine 1,000 mg/m2 Days 1 and 8 every 21 days
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
          </group>
          <group group_id="O3">
            <title>Platinum, Pemetrexed, Cetuximab (Arm C)</title>
            <description>Patients with squamous histology will receive pemetrexed and either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion. Patients with non-squamous histology are not eligible for this arm.
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Survival by Treatment Arm</title>
          <population>Two subjects in Arm A were censored due to negative event intervals.</population>
          <units>Months</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="233"/>
                <count group_id="O2" value="236"/>
                <count group_id="O3" value="130"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" lower_limit="8.3" upper_limit="11.4"/>
                    <measurement group_id="O2" value="8.3" lower_limit="7.1" upper_limit="9.9"/>
                    <measurement group_id="O3" value="10.6" lower_limit="8.0" upper_limit="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1-year Survival by Treatment Arm</title>
        <time_frame>Survival was measured from the date of randomization to date of death due to any cause, assessed up to 36 months. Subjects who were alive at the date of last contact were censored at the date of last contact.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Paclitaxel, Carboplatin, Cetuximab (Arm A)</title>
            <description>Patients with squamous or non-squamous histologies will receive carboplatin and paclitaxel for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion.
Paclitaxel : Paclitaxel 200 mg/m2 Day 1 every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
          </group>
          <group group_id="O2">
            <title>Platinum, Gemcitabine, Cetuximab (Arm B)</title>
            <description>Patients with squamous or non-squamous histologies will receive gemcitabine with either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion.
Gemcitabine : Gemcitabine 1,000 mg/m2 Days 1 and 8 every 21 days
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
          </group>
          <group group_id="O3">
            <title>Platinum, Pemetrexed, Cetuximab (Arm C)</title>
            <description>Patients with squamous histology will receive pemetrexed and either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion. Patients with non-squamous histology are not eligible for this arm.
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>1-year Survival by Treatment Arm</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="233"/>
                <count group_id="O2" value="236"/>
                <count group_id="O3" value="130"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.7" lower_limit="33.7" upper_limit="46.6"/>
                    <measurement group_id="O2" value="37.2" lower_limit="31.3" upper_limit="44.2"/>
                    <measurement group_id="O3" value="47.3" lower_limit="39.1" upper_limit="57.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Survival by Histology</title>
        <time_frame>Survival was measured from the date of randomization to date of death due to any cause, assessed up to 36 months. Subjects who were alive at the date of last contact were censored at the date of last contact.</time_frame>
        <population>Subjects were stratified by histology prior to randomization to a treatment arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Squamous Cell Histology</title>
            <description>Subjects who were identified as having squamous cell histology, prior to randomization to a treatment arm.</description>
          </group>
          <group group_id="O2">
            <title>Non-squamous Cell Histology</title>
            <description>Subjects who were identified as having non-squamous cell histology, prior to randomization to a treatment arm.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Survival by Histology</title>
          <population>Subjects were stratified by histology prior to randomization to a treatment arm.</population>
          <units>Months</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="200"/>
                <count group_id="O2" value="399"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" lower_limit="7.4" upper_limit="10.1"/>
                    <measurement group_id="O2" value="9.9" lower_limit="8.3" upper_limit="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events collection began at the time the patient signed the informed consent and continued throughout the study until 30 days after the last dose.</time_frame>
      <desc>Systematic Assessment - subjects were assessed for adverse events by a member of the research team every 1-2 weeks.</desc>
      <group_list>
        <group group_id="E1">
          <title>Paclitaxel, Carboplatin, Cetuximab (Arm A)</title>
          <description>Patients with squamous or non-squamous histologies will receive carboplatin and paclitaxel for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion.
Paclitaxel : Paclitaxel 200 mg/m2 Day 1 every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
        </group>
        <group group_id="E2">
          <title>Platinum, Gemcitabine, Cetuximab (Arm B)</title>
          <description>Patients with squamous or non-squamous histologies will receive gemcitabine with either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion.
Gemcitabine : Gemcitabine 1,000 mg/m2 Days 1 and 8 every 21 days
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
        </group>
        <group group_id="E3">
          <title>Platinum, Pemetrexed, Cetuximab (Arm C)</title>
          <description>Patients with squamous histology will receive pemetrexed and either carboplatin or cisplatin for a minimum of four and a maximum of six 21-day cycles, plus cetuximab, and then enter a maintenance phase with single-agent cetuximab. Cetuximab will be given on Day 1, and weekly during chemotherapy, followed by biweekly administration during the maintenance period. The choice of delivering four, five or six cycles of chemotherapy is at the investigator's discretion. The choice of platinum-based chemotherapy is also at the investigator's discretion. Patients with non-squamous histology are not eligible for this arm.
Cisplatin : Cisplatin 75 mg/m2 Day I every 21 days
Carboplatin : Carboplatin AUC 6 Day 1 every 21 days
Cetuximab : Cetuximab will be administered at a loading dose of 400 mg/m2 on Day 1, Cycle 1 and at a dose of 250 mg/m2 weekly during chemotherapy. During the maintenance period, cetuximab will be dosed at 500 mg/m2 every two weeks.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (15.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="109" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="128" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="68" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Febrile Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cardiac Tamponade</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cardio-Respiratory Arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Left Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Myocardial Ischemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Restrictive Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Ulcerative Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Enterocutaneous Fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Esophageal Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastric Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rectal Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Upper Gastrointestinal Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse Reation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Disease Progression</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>General Physical Health Deterioration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Generalized Edema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Multi-Organ Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Peripheral Edema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Spinal Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ulcer Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic Reaction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cytokine Release Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Drug Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lung Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacteremia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Catheter Site Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Clostridial Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Clostridium Difficile Colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Fungemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Infectious Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neutropenic Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Staphylococcal Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urinart Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental Exposure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Humerus Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Infusion Related Reaction</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Medication Error</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pneumothorax Traumatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Radiation Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Recall Phenomenon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Splenic Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Subdural Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thoracic Vertebral Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Toxicity to Various Agents</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood/Bone Marrow Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Eastern Cooperative Oncology Group Performance Status</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ejection Fraction Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lipase Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neutrophil Count</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neutrophil Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Platelet Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Transaminases Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Troponin Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>White Blood Cell Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased Appetite</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Failure To Thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypocalcemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypomagnesemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pain In Extremity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Large Cell Carcinoma Of The Respiratory Tract</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Metastases To Bone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neoplasm Malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Non-Small Cell Lung Cancer Metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion Malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tumor Embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain Edema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Central Nervous System Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Central Pain Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cerebellar Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cerebral Ischemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Grand Mal Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Peripheral Sensory Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Spinal Cord Compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Transient Ischemic Attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Mental Status Changes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Renal Failure Acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchial Obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dyspnea Exertional</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lung Infiltration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pleuritic Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pneumomediastinum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pulmonary Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Respiratory Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Subcutaneous Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Leg Amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Arterial Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Superior Vena Cava Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis Superficial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Venous Valve Ruptured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (15.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="221" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="215" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="119" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" subjects_affected="83" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="105" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="52" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Bone Marrow Failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Febrile Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemorrhage Diathesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lymphatic Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="79" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="91" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="42" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="122" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="49" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thrombocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>White Blood Cell Disorder</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Left Ventricular Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sinus Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Trichomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Cerumen Impaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ear Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ear Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ear Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyperacusis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Inner Ear Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Middle Ear Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Adrenal Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cushingoid</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blepharospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Conjunctival Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dark Circles Under Eyes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dry Eye</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Eye Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Eye Irritation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Eye Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Eye Ptosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Eye Swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lacrimation Increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Optic Nerve Sheath Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Periorbital Edema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Photopsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Retinal Vein Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vision Blurred</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Visual Impairment</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Xerophthalmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Abdominal Distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Lower</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Anal Fissure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="79" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="75" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="39" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dry Mouth</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Esophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Fecal Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Feces Discolored</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Feces Hard</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastritis Hemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastroesophageal Reflux Disease</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gingival Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gingival Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Glossodynia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hematemesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hematochezia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemorrhoidal Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Intestinal Mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lip Dry</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lip Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Mouth Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="98" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="84" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="61" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Oral Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Oral Mucosal Erythema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Oral Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Paresthesia Oral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Perianal Erythema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rectal Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Reflux Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Retching</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Saliva Altered</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Salivary Hypersecretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tongue Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse Drug Reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Catheter Site Discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Catheter Site Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Catheter Site Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chest Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Device Infusion Issue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Device Malfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Device Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Disease Progression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Drug Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Early Satiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Edema</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Extravasation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Face Edema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="131" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="131" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="76" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Feeling Hot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Feeling Jittery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gait Disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>General Physical Health Deterioration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>General Symptom</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Implant Site Scar</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Inflammatory Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Influenza Like Illness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Infusion Site Extravasation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Injection Site Reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Local Swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Localized Edema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Mucosal Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Performance Status Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Peripheral Edema</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sensation of Pressure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Soft Tissue Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Temperature Intolerance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tenderness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thirst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Xerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic Function Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyperbiliubinemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Non-Alcoholic Steatohepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic Reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Drug Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess Neck</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Bacterial Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Carbuncle</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Catheter Site Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Conjunctivitis Infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Device Related Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ear Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Esophageal Candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Eye Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Fungal Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Fungal Skin Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Herpes Zoster</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Localized Infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lung Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lyme Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nail Bed Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nail Bed Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nail Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Onychomycosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Oral Candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Oral Herpes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Oral Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Otitis Externa</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Otitis Media</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Perineal Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pharyngitis Bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Scrotal Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Candida</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Staphylococcal Bacteremia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Staphylococcal Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Staphylococcal Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Subcutaneous Abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tinea Cruris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tinea Pedis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tooth Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Upper Aerodigestive Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vaginal Infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Viral Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vulvitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Mycotic Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Aortic Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Arthropod Bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chemical Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Infusion Related Reaction</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Joint Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Muscle Strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Procedural Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Radiation Mucositis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Radiation Skin Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Recall Phenomenon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rib Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Scratch</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Subdural Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sunburn</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Toxicity To Various Agents</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Upper Limb Fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Venous Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Activated Partial Thromboplastin Time Prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Alanine Aminotransferase</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Alanine Aminotransferase Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Alanine Aminotransferase Increased</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Amylase Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Aspartate Aminotransferase</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Aspartate Aminotransferase Increased</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Biopsy Endometrium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Albumin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Albumin Decreased</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Alkaline Phosphatase</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Alkaline Phosphatase Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Alkaline Phosphatase Increased</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Bicarbonate Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Bicarbonate Decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Bilirubin Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Bilirubin Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Calcium Decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Chloride Decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Cholesterol Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Creatinine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Electrolytes Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Glucose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Glucose Decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Glucose Increased</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Lactate Dehydrogenase Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Magnesium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Magnesium Decreased</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Phosphorus Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Potassium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Potassium Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Potassium Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Pressure Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Pressure Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Sodium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Sodium Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Sodium Increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Urea Decreased</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Urea Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood Uric Acid Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blood/Bone Marrow Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Breath Sounds Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chest X-Ray Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Coagulation Factor Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Eastern Cooperative Oncology Group Performance Status</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="39" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Eastern Cooperative Oncology Group Performance Status Worsened</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ejection Fraction Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gamma-Glutamyltransferase</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Glomerular Filtration Rate Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Heart Rate Irregular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hematocrit</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hematocrit Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hematology Test Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemoglobin</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemoglobin Decreased</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hepatic Enzyme Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyperlipidemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>International Normalized Ratio Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>International Normalized Ratio Increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lymphocyte Count</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lymphocyte Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Metabolic Function Test</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neutrophil Count</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neutrophil Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Occult Blood Positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Oxygen Saturation Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Platelet Count</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Platelet Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Protein Total Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Red Blood Cell Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Staphylococcus Test Positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Stool Ph Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Transaminases Increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Troponin I Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urine Color Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urine Output Decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vitamin B12 Deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Weight</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Weight Decreased</sub_title>
                <counts group_id="E1" subjects_affected="119" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="100" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="56" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Weight Increased</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Weight Normal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Decreased Appetite</sub_title>
                <counts group_id="E1" subjects_affected="74" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="63" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="44" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Failure To Thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Glucose Tolerance Impaired</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypercholesterolemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypermagnesemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypernatremia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypoalbuminemia</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypocalcemia</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypomagnesemia</sub_title>
                <counts group_id="E1" subjects_affected="80" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="64" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypophosphatemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypovolemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lactic Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Magnesium Metabolism Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Weight Fluctuation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Bone Pain</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chest Wall Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Flank Pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Groin Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Protusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Joint Stiffness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Joint Swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Limb Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Muscle Spasms</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Muscle Twitching</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Pain</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neck Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pain In Extremity</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pathological Fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Scleroderma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Metastatic Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Papilloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tumor Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>7th Nerve Paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Balance Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Burning Sensation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Central Nervous System Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cognitive Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dyskinesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Facial Paresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyperreflexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypersomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypoesthesia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Loss Of Consciousness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Memory Impairment</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Muscle Contractions Involuntary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nervousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Neuropathy Peripheral</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Paresthesia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Peripheral Motor Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Peripheral Sensorimotor Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Peripheral Sensory Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Peroneal Nerve Palsy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Phantom Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Post Herpetic Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Restless Legs Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sensory Loss</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sinus Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Slow Speech</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tension Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Trigeminal Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal Dreams</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Euphoric Mood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Major Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Mental Status Changes</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Mood Altered</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Personality Change</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Restlessness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sleep Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Tearfulness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Bladder Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Micturition Urgency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Renal Failure Chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Renal Impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urinary Bladder Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urinary Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urine Flow Decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign Prostatic Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Breast Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Breast Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dysfunctional Uterine Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Erectile Dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Genital Burning Sensation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pelvic Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Penile Swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vaginal Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="62" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="74" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="36" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dyspnea Exertional</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Increased Upper Airway Secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lung Infiltration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nasal Congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nasal Discharge Discoloration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nasal Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nasal Dryness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Oropharyngeal Pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Painful Respiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Paranasal Sinus Discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Paranasal Sinus Hypersecretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pleural Fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pleuritic Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Productive Cough</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pulmonary Congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pulmonary Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rales</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Respiratory Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Respiratory Disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Respiratory Distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rhinitis Allergic</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rhinorrhea</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rhonchi</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sinus Congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sputum Discolored</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Stridor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Upper-Airway Cough Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Anhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Decubitus Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dermal Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dermatitis Acneiform</sub_title>
                <counts group_id="E1" subjects_affected="68" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="55" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="32" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Dry Skin</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Exfoliative Rash</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hair Disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hair Growth Abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hirsutism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ingrowing Nail</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lip Ulceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Madarosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nail Discoloration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nail Disorder</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Night Sweats</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Onychalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pain Of Skin</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Palmar-Plantar Erythrodysesthesia Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Penile Ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Photosensitivity Reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pruritus Generalized</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="88" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="100" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="51" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rash Erythematous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rash Macular</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rash Maculo-Papular</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rash Papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Rash Pruritic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Scab</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Atrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Depigmentation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Discoloration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Exfoliation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Fissures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Hyperpigmentation</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Irritation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Ulcer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Subcutaneous Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Subcutaneous Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Swelling Face</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Tobacco User</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Abscess Drainage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Atrial Septal Defect Repair</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Catheter Placement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Central Venous Catheterization</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Cholelithotomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Colony Stimulating Factor Therapy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Medical Device Change</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Nail Operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pleurodesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Sinus Operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Skin Lesion Excision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Therapy Regimen Changed</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hot Flush</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Intermittent Claudication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Ischemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Jugular Vein Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Kawasaki's Disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Lymphedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Pallor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Peripheral Embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Phlebitis Superficial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Raynaud's Phenomenon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis Superficial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
              <event>
                <sub_title>Venous Insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="235"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="130"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The study funder will be provided with a copy of any results communication at least 30 days prior to its submission to a scientific journal or presentation at a scientific meeting to allow review of the publication for confidential information. If confidential information is being disclosed, it may be required to be redacted. Upon request by the study funder, the PI may be asked to withhold disclosure for an additional 90 days to allow the study funder to seek patent protection.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Vice President of Scientific Affairs</name_or_title>
      <organization>Accelerated Community Oncology Research Network, Inc.</organization>
      <email>mwalker@acorncro.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

